Search research articles
Contact Us
Filters
Showing results (101-110 of 164) with videos related to
Page
of 17
Sort By:
British Journal of Haematology
|
October 7, 2009
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group
Mark R Litzow, Megan Othus, Larry D Cripe, et al.
Leukemia Research
|
January 4, 2019
Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes
Judith Neukirchen-Strapatsas, Heinz Tuechler, Matteo Della Porta, et al.
Blood
|
February 26, 2005
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab
John M Bennett, Mark S Kaminski, John P Leonard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2007
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997
Ian W Flinn, Donna S Neuberg, Michael R Grever, et al.
Leukemia Research
|
August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study
Athena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)
Peter L Greenberg, Sandra J Lee, Ranjana Advani, et al.
Journal of Medicinal Chemistry
|
March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres
Young-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl Core
Young-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
The New England Journal of Medicine
|
September 25, 2009
Anthracycline dose intensification in acute myeloid leukemia
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review
Denise M Oliansky, Joseph H Antin, John M Bennett, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 164) with videos related to
Sort By:
Page
of 17
British Journal of Haematology
|
October 7, 2009
Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group
Mark R Litzow, Megan Othus, Larry D Cripe, et al.
Leukemia Research
|
January 4, 2019
Additional prognostic impact of the percentage of erythroid cells in the bone marrow of patients with myelodysplastic syndromes
Judith Neukirchen-Strapatsas, Heinz Tuechler, Matteo Della Porta, et al.
Blood
|
February 26, 2005
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab
John M Bennett, Mark S Kaminski, John P Leonard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2007
Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997
Ian W Flinn, Donna S Neuberg, Michael R Grever, et al.
Leukemia Research
|
August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) study
Athena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995)
Peter L Greenberg, Sandra J Lee, Ranjana Advani, et al.
Journal of Medicinal Chemistry
|
March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres
Young-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
Journal of Medicinal Chemistry
|
August 14, 2020
Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl Core
Young-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
The New England Journal of Medicine
|
September 25, 2009
Anthracycline dose intensification in acute myeloid leukemia
Hugo F Fernandez, Zhuoxin Sun, Xiaopan Yao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 27, 2009
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review
Denise M Oliansky, Joseph H Antin, John M Bennett, et al.
Page
of 17